Article

Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy

2020-08-27

Abstract excerpt

Despite the availability of therapeutic treatments, multiple myeloma is an incurable haematological disorder. In this study, we aimed to clarify the role of CXorf48 as a therapeutic target in multiple myeloma. Based on a previously identified HLA-A*24:02-restiricted epitope from this novel cancer/testis antigen, we characterized the activities of cytotoxic T lymphocytes (CTLs) specific to this antigen against myel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0c343954-679e-583f-b642-61034b541786
DOI: 10.20944/preprints202008.0612.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Characteristics of a Novel Target Antigen against Myeloma Cells for ImmunotherapyDOI 10.20944/preprints202008.0612.v1Read

CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenSemantic proximity Read

Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.Semantic proximity Read

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.Semantic proximity Read

Patients with Multiple Myeloma Have Increased Co-Expression of HLA-E and HLA-DR Molecules on T-Lymphocytes and Monocytes in Peripheral BloodSemantic proximity Read

Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen‐specific cellular immunitySemantic proximity Read

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class ISemantic proximity Read

Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.Semantic proximity Read

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.Semantic proximity Read

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cellsSemantic proximity Read

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease.Semantic proximity Read

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myelomaSemantic proximity Read

HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.Semantic proximity Read